Press

Laboratories can double or even triple the throughput of all existing equipment running the COVID-19 test SALT LAKE CITY – March 17, 2020 – Molecular diagnostics company XCR Diagnostics has [...]

Molecular diagnostics company XCR Diagnostics has been awarded a patent by the United States Patent and Trademark Office for its technology that speeds up the testing and identification process [...]

NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, and XCR Diagnostics, a sample-to-result systems company focused on actionable near [...]

Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR's proprietary Xtreme Chain Reaction nucleic acid [...]